Health-related quality of life in patients with systemic lupus erythematosus after medium to long-term follow-up of hip arthroplasty

Lupus

Volumn 16, Issue 5, 2007, Pages 318-323

  Ito, Hiroshi ^a   Matsuno, T ^a   Hirayama, T ^a   Tanino, H ^a   Minami, A ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Health related quality of life (HRQOL); Hip arthroplasty; Osteonecrosis of the femoral head (ONF); Systemic lupus erythematosus (SLE)

Indexed keywords

ADULT; ARTHROPLASTY; ARTICLE; BONE NECROSIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HIP ARTHROPLASTY; HUMAN; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SHORT FORM 36; SYSTEMIC LUPUS ERYTHEMATOSUS; TOTAL HIP PROSTHESIS;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; FOLLOW-UP STUDIES; HEALTH; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY OF LIFE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34447509609     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307077989     Document Type: Article

References (38)

1. Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with-systemic lupus erythematosus. JAMA 1960; 174: 966-984.
2. Weiner ES, Abeles M. Aseptic necrosis and glucocorticosteroids in systemiclupus erythematosus: a reevaluation. J Rheumatol 1989; 16: 604-608.
3. Zizic TM, Marcoux C, Hungerford DS, Dansereau J-A, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemiclupus erythematosus. Am J Med 1985; 79: 596-604.
4. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997; 24: 654-662.
5. Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis 2000; 59: 462-467.
6. Nagasawa K, Tada Y, Koarada S, Horiuchi T, Tsukamoto H, Murai K, Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 2005; 14: 385-390.
7. Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, Hallet DC, Cook RJ. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 761-765.
8. Sarmiento A, Ebramzadeh E, Gogan WJ, McKellop HA. Total hip arthroplasty with cement: a long-term radiographic analysis in patients who are older than fifty and younger than fifty years. J Bone Joint Surg Am 1990; 72: 1470-1476.
9. Stulberg BN, Singer R, Goldner J, Stulberg J. Uncemented total hip arthroplasty in osteonecrosis: a 2- to 10-year evaluation. Clin Orthop 1997; 334: 116-123.
10. Callahan CM, Drake BG, Heck DA, Dittos RS. Patient outcomes followingtricompartmental total knee replacement: a meta-analysis. JAMA 1994; 271: 1349-1357
11. Baron JA, Barrett J, Katz JN, Liang MH. Total hip arthroplasty: use and select complications in the US Medicare population. Am J Publ Health 1996; 86: 70-72.
12. Coyte P, Wang PP, Hawker G, Wright JG. The relationship between variationsin knee replacements utilization rates and reported prevalence of arthritis Ontario, Canada. J Rheumatol 1997; 24: 2403-2412
13. Bayley KB, London MR, Grunkemeier GL, Lansky DJ. Measuring the success of treatment in patient terms. Med Care 1995; 33(Suppl): AS226-235.
14. Rissanen P, Aro S, Sintonen H, Slattis P Paavolainen P. Quality of life and functional ability in hip and knee replacement: a prospective study. Qual Life Res 1996; 5: 56-64.
15. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME. Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. J Rheumatol 2000; 27: 1745-1752.
16. Thumboo J, Fong KY, Chan SP et al. A prospective study of factorsaffecting quality of life in systemic lupus erythematosus. J Rheumatol 2000; 27: 1414-1420.
17. Dobkin PL, da Costa D, Dritsa M et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res 1999; 12: 401-410.
18. Rinaldi S, Ghisi M, Iaccarino L et al. Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 55: 427-433.
19. Prupas HM, Patzakis M, Quismorio FP Jr. Total hip arthroplasty foravascular necrosis of the femur in systemic lupus erythematosus. Clin Orthop Relat Res 1981; 161: 186-190.
20. Kunec JR. Total hip replacement in patients under thirty-five years of age. Orthopaedics 1983; 6: 1432-1434.
21. Chen PG, Lin CC. Total hip arthroplasty in patients with systemic lupus erythematosus. Taiwan Yi Xue Hui Za Zhi 1987; 86: 299-306.
22. Hanssen AD, Cabanela ME, Michet CJ Jr. Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Joint Surg Am 1987; 69: 807-814.
23. Huo MH, Salvati EA, Browne MG, Pellicci PM, Sculco TP, Johanson NA. Primary total hip arthroplasty in systemic lupus erythematosus. J Arthroplasty 1992; 7: 51-56
24. Zangger P, Gladman DD, Urowitz MB, Bogoch ER. Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus. J Rheumatol 2000; 27: 919-923.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey(SF-36). I: conceptual framework and item selection. Med Care 1992; 30: 473-483.
26. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes following total hip and knee arthroplasty in osteoarthritis. J Orthop Rheumatol 1988; 1: 95-108.
27. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15:1833-1840.
28. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 51: 1037-1044.
29. Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 1998; 51: 1045-1053.
30. Harris WH. Traumatic arthritis of the hip after dislocation and acetabularfracture: Treatment by mold arthroplasty. J Bone Joint Surg Am 1969; 51: 737-755.
31. Harris WH, Schiller AL, Scholler J-M, Freiberg RA, Scott R. Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am 1976; 58: 612-618.
32. Callaghan JJ, Dysart SH, Savory CG. The uncemented porous-coatedanatomic total hip prosthesis: Two-year results of a prospective consecutive series. J Bone Joint Surg Am 1988; 70: 337-346
33. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14(Suppl 13): 223-226.
34. Toloza SM, Uribe AG, McGwin G Jr et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictorsof vascular events. Arthritis Rheum 2004; 50: 3947-3957.
35. Ito H, Matsuno T, Kaneda K. Bipolar hemiarthroplasty for osteonecrosis of the femoral head: a 7- to 18-year followup. Clin Orthop Relat Res 2000; 374: 201-211.
36. Lieberman JR, Berry DJ, Montv MA et al. Osteonecrosis of the hip: management in the twenty-first century. J Bone Joint Surg Am 2002; 84: 834-853.
37. Lee SB, Sugano N, Nakata K, Matsui M, Ohzono K. Comparisonbetween bipolar hemiarthroplasty and THA for osteonecrosis of the femoral head. Clin Orthop Relat Res 2004; 424: 161-165.
38. Kim YH, Oh SH, Kim JS, Koo KH. Contemporary total hip arthroplasty with and without cement in patients with osteonecrosis of the femoral-head. J Bone Joint Surg Am 2003; 85: 675-681.